Center-Authored Papers

Filters: Author is Mielcarek, M  [Clear All Filters]
2017
Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ et al..  2017.  Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.. Cancer. Abstract
Kanakry CG, Bolaños-Meade J, Kasamon YL, Zahurak M, Durakovic N, Furlong T, Mielcarek M, Medeot M, Gojo I, Smith DB et al..  2017.  Low immunosuppressive burden after HLA-matched related or unrelated BMT using post-transplantation cyclophosphamide.. Blood. Abstract
2016
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg HJ, Sorror M et al..  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.. The New England journal of medicine. 375(10):944-53. Abstract
Woo J, Deeg HJ, Storer B, Yeung C, Fang M, Mielcarek M, Scott BL.  2016.  Factors Determining Responses to Azacitidine in Patients with MDS and AML with Early Post-Transplant Relapse: a Prospective Trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Mielcarek M, Furlong T, O'Donnell PV, Storer BE, McCune JS, Storb R, Carpenter PA, Flowers MED, Appelbaum FR, Martin PJ.  2016.  Post-transplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.. Blood. Abstract
Zhou Y, Othus M, Araki D, Wood BL, Radich JP, Halpern AB, Mielcarek M, Estey EH, Appelbaum FR, Walter RB.  2016.  Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia.. Leukemia. Abstract
2015
Seo S, Boeckh M, Storer BE, Schubert MM, Rotta M, Sandmaier BM, Mielcarek M.  2015.  The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 50(3):444-8. Abstract
Mielcarek M, Furlong T, Storer BE, Green ML, McDonald GB, Carpenter PA, Flowers MED, Storb R, Boeckh MJ, Martin PJ.  2015.  Effectiveness and safety of lower-dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.. Haematologica. 100(6):842-8. Abstract
Araki D, Wood BL, Othus M, Radich JP, Halpern AB, Zhou Y, Mielcarek M, Estey EH, Appelbaum FR, Walter RB.  2015.  Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Doney KC, Mielcarek M, Stewart FM, Appelbaum FR.  2015.  Hematopoietic Cell Transplantation after Solid Organ Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(12):2123-8. Abstract
2014
Kanakry CG, O'Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, Mielcarek M, Champlin RE, Jones RJ, Thall PF et al..  2014.  Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(31):3497-505. Abstract
Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, Mielcarek M, Shulman H, Storb R, Nash RA.  2014.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 49(7):966-71. Abstract
Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL, Leboeuf M, Bogunovic M, Storb R, Inamoto Y et al..  2014.  Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation.. Transplantation. 98(5):563-8. Abstract
Inamoto Y, Martin PJ, Storer BE, Mielcarek M, Storb RF, Carpenter PA.  2014.  Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.. Haematologica. 99(2):385-91. Abstract
2013
Sato M, Storb R, Loretz C, Stone D, Mielcarek M, Sale GE, Rezvani AR, Graves SS.  2013.  Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.. Transplantation. 96(1):34-41. Abstract
Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh MJ.  2013.  CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.. Blood. 122(7):1316-1324. Abstract
Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F et al..  2013.  Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(12):1530-8. Abstract
Storb R, Gyurkocza B, Storer BE, Maloney DG, Sorror ML, Mielcarek M, Martin PJ, Sandmaier BM.  2013.  Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):792-8. Abstract
2012
Mielcarek M, Storer B, Martin PJ, Forman SJ, Negrin RS, Flowers ME, Inamoto Y, Chauncey TR, Storb R, Appelbaum FR et al..  2012.  Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.. Blood. 119(11):2675-2678. Abstract
Ram R, Storer BE, Mielcarek M, Sandmaier BM, Maloney DG, Martin PJ, Flowers MED, Chua BK, Rotta M, Storb R.  2012.  Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(3):414-422. Abstract
2011
Rezvani AR, Storer BE, Storb R, Mielcarek M, Maloney DG, Sandmaier BM, Martin PJ, McDonald GB.  2011.  Decreased Serum Albumin as a Biomarker for Severe Acute Graft-vs-Host Disease after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(11):1594-1601. Abstract
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P et al..  2011.  Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.. JAMA : the journal of the American Medical Association. 306(17):1874-83. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Mielcarek M, Storb R, Georges GE, Golubev L, Nikitine A, Hwang B, Nash RA, Torok-Storb B.  2011.  Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(2):214-25. Abstract